Hostname: page-component-848d4c4894-r5zm4 Total loading time: 0 Render date: 2024-06-21T15:45:44.018Z Has data issue: false hasContentIssue false
  • English
  • Français

Mianserin for the rapid improvement of chronic akathisia in a schizophrenia patient

Published online by Cambridge University Press:  16 April 2020

Rafael Stryjer ,
Daniel Grupper ,
Rael Strous ,
Michael Poyurovsky  and
Abraham Weizman
Rafael Stryjer*
Affiliation:
Beer Yaakov Mental Health Center, Beer Yaakov 70350, Israel Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Daniel Grupper
Affiliation:
Beer Yaakov Mental Health Center, Beer Yaakov 70350, Israel Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Rael Strous
Affiliation:
Beer Yaakov Mental Health Center, Beer Yaakov 70350, Israel Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Michael Poyurovsky
Affiliation:
Tirat Carmel Mental Health Center, Tirat Carmel, Israel Faculty of Medicine, Israel Institute of Technology (Technion), Haifa, Israel
Abraham Weizman
Affiliation:
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel Geha Mental Health Center and Felsenstein Medical Research Center, Beilinson Campus, Petah Tiqva, Israel
*
*Corresponding author.

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letter to the Editor
Information
European Psychiatry , Volume 19 , Issue 4 , June 2004 , pp. 237 - 238
Copyright
Copyright © European Psychiatric Association 2002

References

Barnes, TRBraude, WS.Akathisia variants and tardive dyskinesia. Arch Gen Psychiatry 1985;42:874–8.CrossRefGoogle ScholarPubMed
Jones, NDuxon, MSKing, SM.5H2C receptor mediation of unconditioned escape behavior in the unstable elevated exposed plus maze. Psychopharmacology (Berl) 2002;164:214–20.CrossRefGoogle Scholar
Mihara, KYasui-furukori, NKondo, TIshida, MOno, SOhkubo, Tet al. Relationship between plasma concentrations of trazodone and its active metabolite, m-chlorophenylpiperazine, and its clinical effect in depressed patients. Ther Drug Monit 2002;24:563–6.CrossRefGoogle ScholarPubMed
Poyurovsky, MWeizman, A.Serotonin-based pharmacotherapy for acute neuroleptic-induced akathisia: a new approach to an old problem. Br J Psychiatry 2001;179:4–8.Google Scholar
Spivak, BMester, RAbesgaus, JWittenberg, NAdlersberg, SGonen, Net al. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients. J Clin Psychiatry 1997;58:318–22.CrossRefGoogle ScholarPubMed
Stryjer, RStrous, RDBar, FPoyurovsky, MWeizman, AKotler, M.Treatment of neuroleptic induced akathisia with the 5HT2A antagonist trazodone. Clin Neuropharmacol 2003;26(3):137–41.CrossRefGoogle Scholar
Zhang, WPerry, KWWong, DTPotts, BDBao, JTollefson, GDet al. Synergic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex. Neuropsychopharmacology 2000;23: 250–62.CrossRefGoogle Scholar
Submit a response

Comments

No Comments have been published for this article.